WallStSmart
TNXP

Tonix Pharmaceuticals Holding Corp

NASDAQ: TNXP · HEALTHCARE · BIOTECHNOLOGY

$12.93
+4.27% today

Updated 2026-04-30

Market cap
$183.68M
P/E ratio
P/S ratio
14.01x
EPS (TTM)
$-14.57
Dividend yield
52W range
$12 – $70
Volume
0.4M

Tonix Pharmaceuticals Holding Corp (TNXP) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-23568.00$-27869.00$-17982.00$-2.64M$-5.71M$-8.52M$-22.84M$-42.53M$-37.31M$-19.13M$-23.97M$-26.68M$-48.57M$-75.56M$-98.05M$-102.00M$-60.92M$-99.84M
Capital expenditures$0.00$0.00$0.00$2764.00$35673.00$15000.00$319000.00$238000.00$66000.00$5000.00$6000.00$17000.00$8.56M$35.31M$48.15M$7.89M$120000.00$3.37M
Depreciation$9300.00$14329.00$17000.00$36000.00$161000.00$206000.00$70000.00$54000.00$26000.00$27000.00$50000.00$1.25M$4.29M$3.42M
Stock-based comp$435651.00$865158.00$1.72M$3.09M$4.39M$3.27M$1.79M$1.63M$1.46M$2.88M$7.90M$10.91M$9.28M$4.78M$6.02M
Free cash flow$-23568.00$-27869.00$-17982.00$-2.64M$-5.75M$-8.53M$-23.16M$-42.77M$-37.38M$-19.13M$-23.98M$-26.70M$-57.13M$-110.86M$-146.20M$-109.90M$-61.05M$-103.21M
Investing cash flow$302.00$-35763.00$-15000.00$-392000.00$-24.17M$16.59M$7.17M$-6000.00$-17000.00$-8.56M$-35.31M$-48.15M$-29.07M$-120000.00
Financing cash flow$50000.00$10000.00$2.61M$7.49M$14.95M$53.22M$47.69M$20.50M$18.52M$23.54M$12.92M$123.11M$212.49M$87.84M$36.52M$134.87M
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.27M$2.47M$451000.00$6.66M
Share repurchases
Debt repayment
Net change in cash$-24236.00$1.74M$6.42M$29.98M$-19.01M$-234000.00$6.55M$-451000.00$-13.78M$65.97M$101.62M